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Abstract
Background: Guideline producers are increasingly producing versions of guidelines for the public. The aim of
this study was to explore what patients and the public understand about the purpose and production of clinical
guidelines, and what they want from clinical guidelines to support their healthcare decisions.
Methods: Participants were purposively selected to represent a range of the likely users of patient versions of
guidelines, including individuals with health conditions (diabetes and depression), general members of the public,
health communication professionals and a group of young people. Participants were asked about their awareness
and understanding of clinical guidelines and presented with scenario recommendations, or draft materials from
patient guidelines to prompt discussion. Each discussion was facilitated by one or two researchers. All focus groups
were recorded and transcribed prior to analysis. Data were analysed using framework analysis.
Results: We ran nine focus groups involving 62 individuals, supplemented by four interviews with people
experiencing homelessness. Eight groups were held in Scotland, one in England. The four interviews were held
in Scotland. The framework analysis yielded five themes: access and awareness; what patients want to know;
properties of guidelines; presenting evidence; and format. Awareness of guidelines was low. Participants
emphasised the need for information that enables them to choose between treatment options, including
harms. They would like help with this from healthcare professionals, especially general practitioners. Participants
differed in their support for the inclusion of numerical information and graphs.
Conclusions: Members of the public want information to help them choose between treatments, including
information on harms, particularly to support shared decisions with health professionals. Presenting numerical
information is a challenge and layered approaches that present information in stages may be helpful. Ignoring the
themes identified in this study is likely to lead to materials that fail to support public and patient healthcare
decision making.
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Background
Clinical practice guidelines and health technology assess-
ments have emerged as a source of support to individ-
uals wanting to use research evidence in their healthcare
decisions. The science and methodology behind clinical
practice guidelines has developed enormously over the
last 20 years [1]. Good quality guidelines are now widely
recognised as useful authoritative statements of best
practice across many clinical areas [2, 3]. Guidelines are
typically produced for health care providers but there is
an increasing interest in developing derivative products
for the public and many organisations now produce
patient versions of guidelines. In the UK, for example,
the National Institute for Health and Care Excellence
(NICE) and the Scottish Intercollegiate Guidelines Net-
work (SIGN) produce freely accessible patient versions.
The Finnish Medical Society, Duodecim, publishes pa-
tient versions of national Current Care guidelines and a
comprehensive collection of guideline-based patient in-
formation in Duodecim’s Health Library. Professional
groups are also producing patient versions of their
guidelines, for example, the Netherlands Association of
Post-traumatic Dystrophy.
For patient versions of guidelines to be useful, mem-
bers of the public and patients need to know about them
(or their health professionals need to know about them),
the information within them needs to be pertinent to
their healthcare decisions and that information has to be
understandable. This is not always the case, as our earl-
ier literature review found [4]. Others have also
highlighted challenges, for example, that public and pa-
tients may perceive guidelines negatively as a way to
ration access to medications [5], or that research infor-
mation is often general when what people want is infor-
mation that is very specific to them [6]. Indeed, even for
guidelines directed at health professionals, alternative
presentation methods, especially presenting information
in layers, with the most important coming first, makes it
easier for guideline to be used [7]. In other words, it is
important to know what your users need, and in what
format.
The aim of this study was to explore what patients
and the public understand about the purpose and pro-
duction of clinical guidelines, and what they want from
clinical guidelines to support their healthcare decisions.
It complements our earlier systematic review [4] and is
part of the DECIDE project [8].
Methods
The study involved focus groups with a heterogeneous
purposive sample selected to represent a range of the
likely users of patient versions of guidelines. This in-
cluded individuals with selected health conditions (dia-
betes and depression), members of the public without
experience of the topic of the guideline under discussion,
a group of health communication professionals, and a
group of young people (18 to 25). Diabetes and depres-
sion were selected based on the availability of voluntary
organisations in the SIGN network that were able to fa-
cilitate recruitment and because they had been selected
by the DECIDE project management group as being
relevant to all countries within DECIDE. Nine focus
groups were undertaken in total.
Participants were asked about their awareness and un-
derstanding of clinical guidelines and were presented
with scenario recommendations, or draft materials from
patient guidelines to prompt discussion (see Additional
file 1). The questions and materials shown to the groups
followed an iterative process of development and were
revised for use with the different groups sampled. All
focus groups took place between May and November
2012, in eight in locations across Scotland, and one in
England. All were 30 to 90 min long. All focus groups
were recorded and transcribed prior to analysis. Each
group was facilitated by one or two researchers and
hand-written notes were taken to capture relevant non-
verbal communication.
The focus groups were supplemented with four semi-
structured interviews with people experiencing home-
lessness, using draft patient guideline materials to
prompt discussion. Interviews were conducted with this
group because they provided a more flexible format that
seemed to work better for the people experiencing
homelessness. All interviews were audio recorded and
transcribed prior to analysis. Focus groups were con-
ducted by several members of the working group (MC,
KG, KL, & ST).
Participants
Participants for the focus groups were recruited through
the Scottish Health Research Register (SHARE) [9], the
Scottish Health Council (SHC), the Scottish Intercollegiate
Guidelines Network (SIGN) network of voluntary organisa-
tions and the University of Dundee. The communication
professionals were recruited with the help of Sense About
Science [10]. The communication professionals were in-
cluded as part of a heterogeneous sample of the public.
They were purposively selected because communication
professionals provide much of the material patients and the
public receive. We were interested in their views on what
the public and patients (i.e. their audiences) knew about
guidelines and what opinions they had on how guideline
producers could make their own health communication
jobs easier. The communication professionals included
journalists/multimedia managers and editors from UK
based voluntary organisations, newspapers, journals and
broadcasting companies. They all used guidelines as the
basis for some of the material they produced for the public.
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A total of 62 people participated in the focus groups;
each group was composed of between four and 11 partici-
pants (see Table 1). Participants were recruited from a
range of geographical locations across Scotland, with the
exception of the focus group with communication profes-
sionals which took place in England. This group was held
in London, England because it was a more convenient lo-
cation for the participants. Communication professionals
in England may often access different resources and
guidelines than those based in Scotland but their general
requirements are likely to be similar.
The four people experiencing homelessness, one woman
and three men, were recruited via National Health Service
(NHS) Tayside Health Board.
Ethics
Ethics approval for work done by KL and ST was given
by the University of Dundee, where both worked at the
time. Other aspects of this research were undertaken as
part of SIGNs service evaluation. Information on the
planned data collection for the DECIDE project was pro-
vided to the East of Scotland Research Ethics Service
and they confirmed that it did not require full ethics
committee review under the terms of the Governance
Arrangement for Research Ethics Committee (GAfREC)
in the UK. All participants were provided with study in-
formation, assured of confidentiality, and informed that
they could withdraw consent at any time. All partici-
pants provided written consent.
Data analysis
All analysis was carried out using QSR NVivo10®.
NVivo® is software that supports qualitative and mixed
methods research. The data were analysed using the
framework analysis technique described by Ritchie &
Spencer [11]. This method involves a number of separate
but interconnected stages of rigorous and methodical
qualitative analysis (Table 2 contains a description of
the stages of framework analysis). It allows for the
use of a priori themes linked to the study objectives,
and for emergent themes to arise from the data. A
number of themes were identified from the interview
schedules and the previous work of DECIDE [4],
however the majority of themes emerged directly
from the data.
Two researchers (NF & JK) examined all the tran-
scripts independently, and met to discuss and agree an
initial thematic framework. Subsequently they carried
out the indexing and charting stages independently and
met to review and agree all findings derived from the
data. The researchers who conducted the focus groups/
interviews also examined the findings of the analysis, to
ensure the themes identified were an accurate reflection
of the material.
Results
The framework analysis yielded five themes, each with a
set of sub-themes. The five themes have been grouped
into two overarching themes: The guideline and The
Table 1 Details of focus groups
Focus group Participant type Number Gender Age range Location
G1 No medical condition. Recruited from
Dundee University.
7 7 female 30s – 60s Dundee, Scotland
G2 People with a diagnosis of diabetes.
Recruited from Diabetes UK, via the SIGN
network of voluntary organisations.
7 4 male, 3 female 40 - 75 Glasgow, Scotland
G3 No medical condition. Recruited from the
SIGN network of patient organisations.
4 1 male, 3 female 45 - 75 Inverness, Scotland
G4 People with a diagnosis of depression.
Recruited via the SIGN network of
voluntary organisations.
7 3 male, 4 female 30 - 75 Edinburgh, Scotland
G5 No medical condition Recruited through
Scottish Health Research Register (SHARE)
and the University of Dundee.
7 6 male, 1 female 41 – 70 Dundee, Scotland
G6 Young people. Recruited by the Scottish
Health Council.
5 2 male, 3 female 18-25 Glasgow, Scotland
G7 Health communications professionals including
representatives from the voluntary sector, media,
and academic journals.
11 3 male, 8 female not recorded London, England
G8 No medical condition. Recruited through Scottish
Health Research Register (SHARE) and the
University of Dundee.
9 2 male, 7 female 40s-60s Dundee, Scotland
G9 No medical condition. Recruited through Scottish
Health Research Register (SHARE)
5 1 male, 4 female 40s – 70s Dundee, Scotland
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guideline user, as displayed in Fig. 1. The full analysis
tables and participant quotes to further illustrating
the findings of this analysis are available in the
Additional file 2. The charting stage (see Table 2) of
the framework analysis explicitly seeks differences and
similarities between the samples gathered. Findings
were largely similar across the samples, however all
differences identified have been highlighted under the
themes below.
Overarching theme 1: The guideline user
Theme 1: Access and awareness (see Table 3)
Awareness of guidelines Awareness of clinical guide-
lines overall was low with the exception of the communi-
cation professionals. This lack of awareness of the
existence of clinical guidelines or patient versions clearly
prevents people from accessing them and may underlie
the low number of people in the sample that had done so.
Awareness was higher in people with links to voluntary
organisations/research networks, and people who work in
a health or research field. Those that were aware of clin-
ical guidelines generally had only a vague understanding
of them and the type of evidence that underpins them.
Once made aware of patient versions of guidelines, there
was overwhelming support for increasing access to them
and the benefits that they could bring for patients:
“If you’re seeking to empower, you’ve got to get the
information to the patient…” [P1, G2]
The participants with long term health conditions sug-
gested that patient guidelines should be made available
to all patients at diagnosis.
Table 2 Steps in the framework approach [12]
• Familiarisation – All data sources are read and sorted with reference to
the study objective.
• Identify a thematic framework – Key issues concepts and themes are
identified with reference to the objectives of the study and the work
of the DECIDE project to date.
• Indexing – The thematic framework is applied to all the data sources.
• Charting – A matrix of findings for each theme is developed, allowing
the comparison of different groups. Each cell of the matrix contains a
summary of each group or individuals contributions to the theme,
with a reference that can be directly linked to the original text.
• Mapping and interpretation – All charts and notes were compared to
search for patterns and connections in the data. The process allows for
the exploration of consensus and disagreement both within and
across cases.
Fig. 1 Thematic framework
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Despite the high value placed on health information,
participants indicated that accessing good health infor-
mation can be a challenge. They believed that the NHS
is unable to prioritise the provision of good quality
health information due to limited funding. Anger and
frustration was expressed at the short-sightedness of this
approach, given that information that enables self-
management may reduce costs for health services in the
long-term.
Under-use of the mainstream media in promoting pa-
tient guidelines was identified as a problem. The com-
munication professionals group emphasised the failure
of guideline producers to engage the public in accessing
information directly from their websites. Conversely the
other groups thought that newspapers and magazines
could be used to promote patient guidelines and to in-
spire a more user friendly format for the information
they contain.
Sources of health information Participants identified
three main sources of health information: healthcare
professionals, the internet, and voluntary organisations.
Unsurprisingly General Practitioners (GPs) were a key
source of health information, and specialist nurses were
an important source for people who had chronic health
conditions or were experiencing homelessness. Older
patients, and those without access to a computer,
placed a strong emphasis on the availability of printed
versions of patient guidelines from their healthcare
professionals.
The internet was a widely utilised and valued source
of health information. However, participants also found
that it can be overwhelming and alarming because of the
volume of available information. Identifying trustworthy
sources of online information was important to the par-
ticipants, and in this UK context, NHS websites were
considered the most reliable.
Voluntary organisations were described as an excellent
source of high quality user-friendly health information.
Patients emphasised how helpful they had found them
and expressed frustration over delays with signposting to
non-health sector organisations (e.g. to weight-loss organi-
sations) by health services. Communication professionals
pointed out that voluntary organisations have organisa-
tional objectives and agendas that may lead them to dis-
agree with guideline recommendations:
“…charities have agendas and getting your, you know
your advice on Abiraterone from our website will give
you a very different view from NICE’s [National
Institute for Health and Care Excellence] website
simply ’cause we’re jumping up and down…trying to
get it approved” [P4, G7 Health Professionals]
Access to professionals and treatment Waiting times
and limited time with the GP during an appointment is
a source of frustration for patients seeking health infor-
mation. Lack of sufficient time with the GP for discus-
sion of harms and contraindications was a particular
issue for people with long-term conditions and/or multi-
morbidity. The group of young people indicated that
even the four-hour waiting time for a return call from
NHS24 (a telephone helpline) [13] is too long for this to
be a viable route to health information; by the time of a
call-back they would already have found an alternative
source. This theme of frustrations with access to, and lim-
ited time with, healthcare professionals was widespread
and seemed to underlie the desire to be able to access
health information directly and without the need to make
an appointment with a healthcare professional.
A lack of fairness in access to good health information
and treatment was highlighted by participants. Variability
in the knowledge and communication skills of healthcare
professionals, and the “postcode lottery” of which services
Table 3 Subthemes with illustrative quotes from the access and awareness theme
Subtheme Illustrative quote Participant & group number
Awareness of guidelines Well the questions should be why is nobody asking for that
[patient guideline]? And the response should be do your
patients know they exist? If they say yes, well why have
you still got them? If they say no you say well that’s part
of the problem, you have to tell them.
P2, G2
Sources of health information …I think nowadays when you’re, with any sort of diagnosis
initially, whether it’s going to take you into the blackest hole
in the world or not, the internet’s the place to go.
P1, G5
Access to professionals and treatment You might have something else to ask but their body language
you know if they’re bent over the computer, you might think
that the time is up and you just think oh I’ll just go.
P3, G3
Interacting with healthcare professionals …I don’t want to have to check on what GP is doing, I want to
be able to trust them…but if I can’t, I need to have access to
that information [patient guideline].
P3, G1
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are offered in a given location, leads to “luck” potentially
playing a role in access to good health information and
referrals.
Interacting with health professionals A dominant con-
cern for the participants was the failure of healthcare
professionals (particularly GPs) to provide sufficient in-
formation on treatment options. If insufficient informa-
tion on the range of treatment options was provided
people felt unable to trust their healthcare professionals;
even wondering if information was being purposefully
withheld:
“…the doctors are not always forthcoming as to what’s
on offer.” [P3, G3]
However, patients expressed a strong desire to be able
to trust their healthcare professionals. The patients who
did feel fully able to trust their healthcare professionals
thought that they could rely on them to implement rec-
ommendations from guidelines and they struggled to see
what use they would make of a patient version of a
guideline. Conversely, those with doubts about how
forthcoming their healthcare professionals’ are with in-
formation on treatment options clearly saw the useful-
ness of patient versions of guidelines. These issues of
trust seemed to underlie the concern that healthcare
professionals would react negatively to a patient bringing
a patient version of a guideline to a consultation, or even
raising its contents in discussion.
Theme 2: What patients want to know (see Table 4)
My treatment choices Participants emphasised the
need for information that enables them to choose be-
tween treatment options. Patient versions of guidelines
were considered potentially empowering, in providing
the information necessary for people to discuss specific
treatment preferences, suggest alternatives, and refuse
treatments suggested by healthcare professionals. To
make informed choices participants wanted information
on effectiveness but they wanted this information tai-
lored, taking account of family history, co-morbidities,
harms and lifestyle implications.
The importance of shared decision making, and the need
for input from healthcare professionals when making a
treatment choice, was a recurrent finding. It appears that
some patients are being asked to make health decisions
without the support from healthcare professionals that
they would like, leaving them fearful of making the
wrong decision:
“… it’s putting so much pressure on patients, I had a
friend…she was given loads of information and asked
to make her decision. She said to me why are they
putting it back on me?” [P1, G3]
Harms and lifestyle The provision of information on
harms was a priority for the participants. It was consid-
ered fundamentally important to making an informed
treatment choice. In order to do so patients' required
balanced information that allowed them to judge
whether the benefits of a treatment outweighed the risks
for them as an individual.
Unfortunately participants did not think that healthcare
professionals placed as much emphasis on potential harms
of treatment as patients do. Concern was expressed about
a lack of information provision about the risks, and life-
style implications, of both medicines and surgical inter-
ventions. Less commonly concerns were expressed about
the minimisation of potential risks and side-effects by
healthcare professionals.
What to expect - causes symptoms and outcomes Par-
ticipants wanted good quality information about what to
expect from an illness, and health services throughout its
entire course. This includes information on symptoms,
Table 4 Subthemes with illustrative quotes from the what patients want to know theme
Subtheme Illustrative quote Participant & group number
My treatment choices …it [patient guideline] gives you the knowledge then it gives
you the ammunition to question why you’re getting the
treatment or why you’re not getting treatment.
P1, G5
Harms and lifestyle …the doctor wanted to give me an operation…He didn’t tell
me about the consequences right of what he was going to do.
P2, G5
What to expect - causes symptoms and outcomes …we and our families are living with this illness, we should
know what to expect…
P2, G2
Self-management How to help yourself…Help yourself, yes, I think that’s the top
priority [for patient guidelines]...
P3, G2
Signposting Where you should go. It’s not a case of being spoon-fed because
we’re all adults but if you’re suffering from this or have the signs
of this, this is where you can go for help? We need to know that.
P6, G2
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treatments, causes and possible outcomes. The communi-
cation professionals group highlighted clinical care path-
ways (i.e. the stages of care that will be delivered to a
patient, by which professional and when) as a helpful way
to communicate this information.
Self-management There was consistent demand for patient
versions of guidelines to contain information that enables
self management. Study participants were very interested in
information about any ‘easy’ ways that they can change their
lifestyle to help to manage a condition. For example groups
that were shown obesity guideline materials emphasised the
need for information about how to increase exercise levels
and improve diet. Participants showed an awareness of the
impact of financial drivers behind the provision of health in-
formation; they were keen to point out that good quality
health information, focused on self-management, reduces
the need for input from health services:
“Don’t forget the more information we get, the better
we can look after ourselves. If we have these guidelines,
you see him [GP] less…” [P2, G2]
Signposting Patient versions of guidelines should con-
tain information that refers users to appropriate sources
of support and places to access treatment. Participants
made it clear that it is not sufficient to provide links to web-
sites when signposting an organisation. This was key for
some groups such as older people, for whom information
on services that can be accessed by telephone or by person-
ally dropping into a health centre is particularly important.
Overarching theme 2: The guideline
Theme 3: Properties of guidelines (see Table 5)
Language and tone A dominant theme was the need
for simple language in patient versions of guidelines.
This included minimising the use of medical and
technical language, keeping sentences and paragraphs
short, and avoiding ambiguity. Medical terminology was
identified as the key barrier to patients and clinicians
using the same guideline. In fact, the use of language
that the majority of the public cannot understand can be
interpreted as purposefully misleading:
“…in case you get a doctor who doesn’t want people to
know much, and then he writes it in medical terms so
it, it completely blinds you” [P2, G5]
Participants frequently found the tone of patient version
guideline materials negative and dogmatic, particularly
when a lack of evidence for an intervention was
highlighted. Terms such as “there is no good evidence” were
considered ambiguous and unhelpful. In contrast any at-
tempt to emphasise the positive was more appealing.
Meaningfulness It must be evident quickly that a pa-
tient version of a guideline is aimed at the patient group
concerned and contains information on what the patient
wants to know to encourage them to read it. Design as-
pects are important in appealing to the user group in-
cluding the use of meaningful images and colour.
Content and lay out is also key, for example participants
did not want information on how guidelines were pro-
duced to be overly prominent, since this distracted from
the information on the condition and how to manage it.
The usefulness of patient involvement in research and
guideline development was highlighted. This can greatly in-
crease the meaningfulness of the guideline to the patient,
particularly in ensuring that key outcomes are reported on:
“I think it’s important that they do go to Patient
Groups when they’re doing their guidelines…because
patients will soon tell you, you know what matters to
them about coping with their condition…” [P3, G1]
Table 5 Subthemes with illustrative quotes from the properties of guidelines
Subtheme Illustrative quote Participant & group number
Language and tone “…there was a lot of medical jargon…I know from experience
and you know congratulations for producing this booklet
[SIGN patient guideline] but patient themselves cannot all
read it…
P2, G4
Meaningfulness There’s no point in teaching somebody, or getting somebody
to look at how the guidelines are produced when they’re
actually wanting to find out ”What Is Obesity"?
Interview 1
Trustworthiness and credibility …it gives it more weight if it’s based on a guideline…because
you assume…even…if you don’t understand exactly what a
“guideline” means…that it’s based on some evidence from
somewhere that this is a good thing to do, someone’s looked
at some evidence and made a guideline…
P4, G1
Guidelines as restrictors of access to treatment …CBT is the one that doctors know about but it’s not the
only solution, and I think that this idea that because there is
evidence then you’ve got to refer people to CBT, I think it’s
really really dangerous…
P1, G4
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Trustworthiness and credibility The source of guide-
lines’ credibility is the understanding that they are based
on a thorough review of the available evidence. The
threats to guideline credibility that participants noted
included healthcare professionals’ ability to disregard
them, the perception that strong evidence for effective-
ness is ignored if the costs of a treatment are high, and
changes to recommendations (i.e. something is said to
harmful and later said to be beneficial, or vice versa). An
example of this was confusion resulting from changes to
government guidelines e.g. safe consumption of alcohol.
Providing a clear rationale for any changes may aid
acceptance and minimise patients’ frustration. Concerns
about the role of financial considerations extended to
potential conflicts of interest in pharmaceutical companies
and manufacturer’s funding of research and information
for patients. NHS branded information was considered
the most trustworthy.
Guidelines as restrictors of access to treatment There
was a strong concern about guideline recommendations
leading to decreased access to treatment, from groups
other than the communication professionals. The per-
ception that the decision to not recommend an interven-
tion is based on costs rather than effectiveness leads to a
negative perception of guideline bodies. In contrast, the
communication professionals saw UK guideline bodies
in a positive light. They considered them (e.g. NICE) to
be objective and to represent a gold standard in guide-
line methodology. They suggested that this mispercep-
tion of guideline bodies could be addressed by a more
sophisticated media management strategy.
The lack of evidence for complex interventions “that
just aren’t easy to trial…”, or that fail to attract funding
for research, is also of concern. People fear that clinical
guidelines will lead to access to these interventions being
withdrawn or referrals to treatments with a stronger evi-
dence base than their preferred option.
Presenting evidence (see Table 6)
Numbers The participants fell broadly into two groups
in relation to numerical information. The first group
found information presented in a numerical format help-
ful, direct and credible. The other group found tables
containing fairly complex numerical information off put-
ting and suggested supplementing them with simpler
text or graphics. The communication professionals
highlighted the difficulty of interpreting relative risks
without information on absolute risk. They also strongly
supported the use of the simplest numerical information,
such as frequencies, when communicating with patients.
Participants indicated that numerical information can
appear cold and dehumanising, presenting the patient
with a description of the health problem that is diffi-
cult to relate to. Personal stories were able to coun-
terbalance this by putting a human face to the data
being presented. However, personal stories can be
alienating if the reader does not recognise themselves
in the story, or potentially misleading if only one pos-
sible outcome of an intervention is presented. Some
potential patient guideline users found personal stor-
ies unnecessary and preferred the presentation of
more numerical information.
Charts Simple charts were greatly appreciated for their
ability to convey a substantial amount of information
quickly and in a visually attractive format. The commu-
nication professionals thought that online “graphics
really work” to convey complex health information, such
Table 6 Subthemes with illustrative quotes from the presenting evidence theme
Subtheme Illustrative quote Participant & group number
Numbers …in numbers rather than percentages … so if this many people do this,
then…this many people benefit, but…this many people may have a
serious side-effects…
P8, G7
Charts …I personally will look at graphs and, and, and pie charts and things,
but if I saw…this [Prostate cancer screening graphic] I, I just would’nae
…I’d just scoot, scoot over it”
P5, G5
Costs and cost effectiveness I don’t think you need that information [on cost-effectiveness] because
…that’s down to the, the NHS…it’s not down to the patient.
Interview 4
Levels of evidence & recommendations I wouldn’t want to hear it [a recommendation] was weak…I would take
it with a pinch of salt if it’s based on weak evidence and actually I would
think what are they doing producing a recommendation if it’s not strongly
endorsed.
P3, G3
Anecdotal evidence “I joined self-help groups, I think they’ve been helpful to me but there’s no
research evidence to say how effective they are whereas there’s medication
and talking therapies which are quite reasonably researched, you can see the
evidence for them. Other things can be just quite as helpful.
P7, G4
Symbols “What the wee ones wi’ the plus in them?…because what is that for? P10, G8
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as risk and benefit ratios. However, the participants in
other groups again fell into two broad groups, one ex-
pressing a preference for extracting meaning from charts
and the other preferring a text explanation of evidence.
It seemed therefore that both were necessary for all the
participants to make sense of the material.
The simpler and more recognisable the chart (e.g. a sim-
ple bar chart) the more usable and well received it was. A
dominant reaction to more complex charts and graphics
was frustration and confusion and the suggestion that this
material would be discarded or skipped over.
Costs and cost effectiveness The presentation of any
material on costs and cost-effectiveness was disliked and
criticised as irrelevant to patients. They suggested that
they “don’t need to know about costs”. This irrelevance
appeared to stem from a demand for information that
helps to choose between treatment options or enables
self-management, while decisions about costs are “for
the NHS” not the patient. The anger that costs informa-
tion could trigger was strongly linked to the perception
that recommendations against interventions are driven
by costs and not effectiveness, and general concerns
about the funding of healthcare.
In stark contrast to the other groups, the communica-
tion professionals wanted information on costs to be
more accessible, so that the underlying rationale behind
an intervention not being recommended is more evi-
dent. Providing an understandable rationale for decisions
around a recommendation is extremely helpful and may
stop people from assuming that decisions are entirely
based on cost.
Levels of evidence and recommendations There was
widespread surprise and confusion caused by the possi-
bility that recommendations, and interventions them-
selves, may not have a strong evidence base underlying
them. This was, at least in part, due to unfamiliarity with
the concept of levels of evidence, in particular the notion
of poor quality research. Any references to ‘moderate’ or
‘low’ quality evidence or the use of symbols (e.g. the one
to four plus signs used in GRADE [14]) to provide infor-
mation about the quality of evidence was challenging for
the groups to understand. The most widespread view
was that information on the quality of evidence under-
lying recommendations was unnecessary in a patient
version of a guideline; however a less commonly held
perspective was that it would be misleading to withhold
this level of detail.
Overall, the participants did not favour the use of
levels of recommendation in patient versions of guide-
lines and did not understand why such a guideline
would include a recommendation with a large amount
of uncertainty attached to it. When recommendations
were described as ‘weak’ (as done in GRADE), a strong
negative reaction was expressed to the tone of the word
itself, irrespective of the concept underlying it. While
participants understood that a weak recommendation
indicated that the recommendation is less strongly
“endorsed” than a strong recommendation they inter-
preted this in a variety of ways. This included: as an indi-
cation that the intervention itself is not effective, that
the intervention is supported by low quality evidence, or
that the guideline developers are not certain about this
recommendation. Participants wanted an honest explan-
ation of the rationale behind a recommendation. There-
fore avoiding the use of the term weak and instead
giving an understandable explanation of the reasons for
uncertainty was considered the best approach to explain-
ing levels of evidence and recommendation.
To be meaningful to the patient, a patient version of a
guideline has to strike a balance between being too sim-
plistic and being overly complicated and technical. The
amount, and complexity, of information contained in
some materials shown to participants led to ‘information
overload’. They suggested that faced with this level of
complexity they may abandon the patient version of a
guideline and find something simpler. However, partici-
pants were keen to emphasise that ‘one size does not fit
all’ and what might be perceived as insufficient, or
overly complex, information by one person may be ideal
for another. This was reflected in a strong concern
for the provision of appropriate information for people
lacking in health literacy and for people with conditions
that impair cognition (e.g. depression). A sub-group of
our participants, including but not exclusively com-
posed of the communication professionals, wanted ac-
cess to an in-depth summary of the evidence underlying
a recommendation.
Anecdotal evidence The importance of personal experi-
ence and stories of what has happened to family mem-
bers, friends and celebrities in making health decisions
was a strong theme, and it was apparent that this can
override evidence presented to patients. Anecdotal infor-
mation about harms was a particularly recurrent aspect
and seemed to have a powerful impact:
“I’m quite interested in the fact that, does it say
Warfarin doesn’t, doesn’t em ’cause any major lifestyle
changes…yeah whereas people I know have been on it
just hate…you know hate being on it because of the
lifestyle implication” [P1, G9]
Participants found it hard to understand why inter-
ventions that they had found personally helpful would
not appear in a patient version of a guideline. This
may be linked to another commonly expressed view
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that any treatment is “worth a shot”, regardless of the
evidence of effectiveness, if a person’s quality of life is
severely affected by a condition. While some people
did indicate that they would be “put off” a treatment
by a lack of evidence, many suggested that they
would still want to try it if there was any chance it
might be helpful. Descriptions of “natural treatments”
and any intervention that people believed does no
harm (an example given by participants was self-help
groups), as lacking an evidence base were considered
overly negative.
Symbols The G8 group and the people experiencing
homelessness were shown mock guideline materials that
used plus symbols to communicate information about
levels of evidence (see Additional files 3 and 4). Partici-
pants found the use of these symbols confusing, even
when a key was presented on the same page. For the
people in our sample that did not have a healthcare or
research background, communicating meaningfully
about levels of evidence using these symbols did not
work, and a text explanation was also necessary.
Format (See Table 7)
Layering There was consistent and wide-spread support
for layering of information in electronic formats because
it allows access to more complex evidence while keeping
the surface level simple (for examples of layering in
guidelines see Kristiansen 2015 [7]). This was highlighted
as a solution to the problem of providing tailored informa-
tion and a key benefit of online information. People with
multi-morbidity (we did not specifically recruit people
with multi-morbidity but participants self-identified as
having multiple conditions during the research process)
emphasised the importance of information that actively
takes account of their health conditions. While younger
people were very interested in technology that allows
layering of information to the exact level required (e.g.
apps), older people can experience referral to online infor-
mation and other communication technologies as alienat-
ing and frustrating.
Text There was broad support for any form of chunking
[15] in the text, including clear, headed sections, bullet
points, and tables which were liked for their ability to
convey factual information quickly and clearly. Partici-
pants indicated that long sections of unbroken text are
likely to be skipped over until something more attractive
catches the reader’s eye; the shorter and simpler the text
is the more usable the patient version appears to be
guideline. This is particularly true for information pro-
duced as a hard copy, which should be kept short, and
focused, to appeal to the majority of readers. Although it
should be noted that “one size doesn’t fit all” and facili-
tating access to more detailed information will be appre-
ciated by some.
Images and colour Images were found helpful when
they conveyed meaning, such as making a topic obvious
at first glance. Images draw attention to a particular sec-
tion of text, which helps to break it up and make the
guideline more usable and attractive.
The use of images can make a guideline appear more
“personal”, and help to humanise the information being
conveyed, giving the patient guideline a more friendly
appearance. Conversely inappropriate, overly clinical or
poor quality images may make a patient version of a
guideline less attractive and give it a “cheap” appearance.
The use of colour also makes a guideline more attract-
ive and therefore more likely to be read. It is important
to be aware of peoples pre-existing associations with
colour, for example red and its association with danger.
The use of dull and indistinguishable colours in charts,
such as grey and white, was found unhelpful and confus-
ing, as was too many bright colours.
Multiple formats Multiple formats are necessary if pa-
tient versions of guidelines are to be disseminated to the
widest possible audience. Younger people appeared to par-
ticularly value the anonymity, and speed, offered by apps
and Quick Response (QR) codes. However all age groups
recognised that only a minority of people can currently
access patient versions of guidelines in this way, so they
can only supplement other formats. Patient versions of
Table 7 Subthemes with illustrative quotes from the format theme
Subtheme Illustrative quote Participant & group number
Layering I’d quite like a guideline that was on the internet and it had, if you wanted more
information “click here” right and you could then progress…depending on how
much information you wanted.
P3, G1
Text and tables …not too many words close together. People will look at it and think ‘oh I don’t
want to read that’ like seeing a massive text and it’s too much.”
P2, G6
Images and colour …like a caricature, like sort of pointing to the throat or something like a, a man
with a…you know so we know what we’re talking about…
P6, G5
Multiple formats …they should be in a variety of formats, apps, internet so that anyone can source them… P2, G4
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guidelines that were available in multiple formats, such as
simplified versions, hard copy, large text, and video/audio
formats may particularly benefit vulnerable groups.
Discussion
The main aim of this study was to explore what patients
and the public understand about the purpose and devel-
opment of clinical guidelines, and what they want from
clinical guidelines to support their healthcare decisions.
The individuals who contributed to the study represent
a range of people who may access patient versions of
guidelines, including people with long-term conditions,
younger people, homeless people, and other members of
the public, as well as healthcare communication profes-
sionals who use guidelines as the basis for the materials
they produce for the public.
The main message from this study is that those
charged with the development and implementation of
clinical guidelines have a considerable amount of work
to do to increase awareness in the first instance and
make patient versions of guidelines acceptable and use-
ful to patients. Five themes emerged: Access and aware-
ness, What patients want to know, Properties of the
guideline, Presenting the evidence, and Format. These
overlap with the themes coming from our systematic re-
view (with which NF and JK, who led the analysis in the
current study, were not involved): Applicability of guide-
lines, Purpose of guidelines for patient, Purpose of
guidelines for healthcare system and physician, and
Properties of guideline [4]. Again we conclude that these
themes need to be incorporated into the design of pa-
tient versions of guidelines if they are to be useful to the
public and patients.
The public is generally unaware of the existence of
guidelines, though people are enthusiastic about them
once they are made aware of them. It is unlikely that a
guideline website is the first port of call for the majority
of people looking for health information, meaning sign-
posting by health professionals (or their organisations,
such as the NHS) is important. The professional health
communicators group mentioned the importance of
making guidelines easy for charities (several members of
this group worked for charities) to access and under-
stand so that they can incorporate guideline information
into their materials for the public. The relevance of this
advice is easily demonstrated by a Google search of ‘dia-
betes treatment’, which, ignoring paid-for ads, puts the
charity Diabetes UK as the #1 search result, with NICE
at #17 on the second page of results. NHS Choices was
#2, emphasising the importance of using brands that the
public may be more familiar with and, as our study
found, are already trusted.
Participants emphasised the need for information that
enables them to choose between treatment options,
which includes information on harms. Moreover, they
would like help with this from healthcare professionals.
Treatment harms will always be of concern to patients
[16, 17] and healthcare professionals need to be aware
that health information they provide may be competing
with anecdotal information. Making the trade-offs be-
tween harms and benefits, especially when they are
close, is an area where guideline-based tools to support
shared decision making could have an important role, a
point made by others linked to the DECIDE project [18].
Members of same group suggests that production of
these tools can be semi-automated as demonstrated in
the MAGIC guideline project for antithrombotic therapy
[19]. What members of the public do not want is to be
handed a lot of material and then left to make their own
decision, which is a narrow view of shared decision mak-
ing [20]. The public wants input from professionals.
Presenting risk information in patient versions of
guidelines is challenging [4]. Participants in this study
often differed in their support for numerical information
and graphs, and suggested that there is no one-size-fits
all approach. This has led DECIDE to suggest layering of
information in guidelines [7] with the most important
information (generally the recommendation) being pre-
sented first and then users can access more detailed in-
formation if they want it, down to the full evidence
profile. Layering is possible even within a paper docu-
ment using colour or boxes, as done by the Scottish
Dental Clinical Effectiveness Programme in their patient
guideline on preventing gum disease [21] and SIGN in
their glaucoma guideline patient version [22], which at-
tracts readers to the recommendations first.
Strengths and limitations of this study
A strength of the study is that it involved a wide range
of participants from many backgrounds and from across
Scotland. The extent to which the findings are transfer-
able to other populations, particularly non-UK popula-
tions, is uncertain. Qualitative research does not seek to
gather a representative sample of a population but rather
to purposively gather a heterogeneous sample and ex-
plore the transferability of the results beyond the sample
gathered. The findings presented here do concur with
those from our earlier systematic review [4], which was
global in scope. We are confident about the wider rele-
vance of the five themes that emerged from the focus
groups and interviews.
A rigorous method of qualitative analysis was used to
analyse the data, which was led by two researchers (NF
and JK) working independently of each other and who
were not involved in the data collection, or the earlier
review. This has ensured that the themes emerged from
the data, rather than being imposed upon it by the rest
of the team. Finally, we have made our findings tables
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available as a supplemental document so that others
may review it and potentially use if for their own work.
The sample was purposively selected and heterogeneous
in nature and therefore the materials and the exact questions
posed to the participants varied somewhat between the
groups. The materials and questions were tailored to the
groups and developed as the research progressed. Each focus
group/interview focused around the topic of what each
group understood about and wanted from clinical guidelines
and was open in its structure. This did not hinder the ana-
lysis. Given the focus of the research question and the range
of groups included, the focus of the analysis was on similar-
ities across groups and where discussion moved away from
guidelines this material was excluded from the analysis. The
analysis process specifically sought to identify differences be-
tween groups at the charting stage (see Table 2), and where
differences were found they have been highlighted.
There are issues of trust that need to be addressed
alongside efforts to clearly convey the balance of risks and
benefits associated with particular treatments or courses
of action and the importance of evidence when making
potentially life changing decisions. The GRADE process
[23] has been instrumental in clarifying what that balance
might be for specific interventions, and includes the values
and preferences of patients and healthcare professionals.
DECIDE has built on that work to improve the presenta-
tion of that information in ways that are meaningful to
different audiences, including patients.
Conclusions
Members of the public want information to help them
choose between treatments, including information on
harm, particularly to support shared decisions with
healthcare professionals. Presenting numerical informa-
tion is a challenge and layered approaches that present
information in stages may be helpful. Guideline pro-
ducers should carefully consider the themes identified in
this study, together with those from our earlier review
[4], so as to avoid producing materials that fail to sup-
port public and patient healthcare decisions.
The work coming from this study helped to support the
update of the Guideline International Network Toolkit
Chapter 4 on developing patient versions of guidelines [24].
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